259 related articles for article (PubMed ID: 22353833)
21. Trends in stage-specific breast cancer incidence in New South Wales, Australia: insights into the effects of 25 years of screening mammography.
Jacklyn G; McGeechan K; Irwig L; Houssami N; Morrell S; Bell K; Barratt A
Breast Cancer Res Treat; 2017 Dec; 166(3):843-854. PubMed ID: 28822001
[TBL] [Abstract][Full Text] [Related]
22. Trends of in situ carcinoma of the breast in Vaud, Switzerland.
Levi F; Te VC; Randimbison L; La Vecchia C
Eur J Cancer; 1997 May; 33(6):903-6. PubMed ID: 9291813
[TBL] [Abstract][Full Text] [Related]
23. Hormone therapy use and breast cancer incidence by histological subtypes in Sweden and Norway.
Suhrke P; Mæhlen J; Zahl PH
Breast J; 2012; 18(6):549-56. PubMed ID: 23002918
[TBL] [Abstract][Full Text] [Related]
24. Mammography screening in the county of Fyn. November 1993-December 1999.
Njor SH; Olsen AH; Bellstrøm T; Dyreborg U; Bak M; Axelsson C; Graversen HP; Schwartz W; Lynge E
APMIS Suppl; 2003; (110):1-33. PubMed ID: 12739252
[TBL] [Abstract][Full Text] [Related]
25. First epidemiological analysis of breast cancer incidence and tumor characteristics after implementation of population-based digital mammography screening.
Weigel S; Batzler WU; Decker T; Hense HW; Heindel W
Rofo; 2009 Dec; 181(12):1144-50. PubMed ID: 19859859
[TBL] [Abstract][Full Text] [Related]
26. Bilateral breast cancer: early detection with mammography.
Roubidoux MA; Helvie MA; Lai NE; Paramagul C
Radiology; 1995 Aug; 196(2):427-31. PubMed ID: 7617856
[TBL] [Abstract][Full Text] [Related]
27. Screening mammography in women less than age 50 years.
Kerlikowske K
Curr Opin Obstet Gynecol; 2012 Feb; 24(1):38-43. PubMed ID: 22037165
[TBL] [Abstract][Full Text] [Related]
28. Overdiagnosis in screening mammography in Denmark: population based cohort study.
Njor SH; Olsen AH; Blichert-Toft M; Schwartz W; Vejborg I; Lynge E
BMJ; 2013 Feb; 346():f1064. PubMed ID: 23444414
[TBL] [Abstract][Full Text] [Related]
29. [Breast cancer incidence related with a population-based screening program].
Natal C; Caicoya M; Prieto M; Tardón A
Med Clin (Barc); 2015 Feb; 144(4):156-60. PubMed ID: 25194975
[TBL] [Abstract][Full Text] [Related]
30. [Overdiagnosis in mammography screening].
Zahl PH; Maehlen J
Tidsskr Nor Laegeforen; 2004 Sep; 124(17):2238-9. PubMed ID: 15356688
[TBL] [Abstract][Full Text] [Related]
31. Natural history of breast cancers detected in the Swedish mammography screening programme: a cohort study.
Zahl PH; Gøtzsche PC; Mæhlen J
Lancet Oncol; 2011 Nov; 12(12):1118-24. PubMed ID: 21996169
[TBL] [Abstract][Full Text] [Related]
32. Mammographic density and estimation of breast cancer risk in intermediate risk population.
Tesic V; Kolaric B; Znaor A; Kuna SK; Brkljacic B
Breast J; 2013; 19(1):71-8. PubMed ID: 23173778
[TBL] [Abstract][Full Text] [Related]
33. Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness.
Welch HG; Prorok PC; O'Malley AJ; Kramer BS
N Engl J Med; 2016 Oct; 375(15):1438-1447. PubMed ID: 27732805
[TBL] [Abstract][Full Text] [Related]
34. Breast carcinoma in situ in 167 women--incidence, mode of presentation, therapy and follow-up.
Ringberg A; Andersson I; Aspegren K; Linell F
Eur J Surg Oncol; 1991 Oct; 17(5):466-76. PubMed ID: 1657650
[TBL] [Abstract][Full Text] [Related]
35. Overdiagnosis and overtreatment of breast cancer: estimates of overdiagnosis from two trials of mammographic screening for breast cancer.
Duffy SW; Agbaje O; Tabar L; Vitak B; Bjurstam N; Björneld L; Myles JP; Warwick J
Breast Cancer Res; 2005; 7(6):258-65. PubMed ID: 16457701
[TBL] [Abstract][Full Text] [Related]
36. Assessing the impact of screening mammography: Breast cancer incidence and mortality rates in Connecticut (1943-2002).
Anderson WF; Jatoi I; Devesa SS
Breast Cancer Res Treat; 2006 Oct; 99(3):333-40. PubMed ID: 16703451
[TBL] [Abstract][Full Text] [Related]
37. Modelling the impact of detecting and treating ductal carcinoma in situ in a breast screening programme.
McCann J; Treasure P; Duffy S
J Med Screen; 2004; 11(3):117-25. PubMed ID: 15333269
[TBL] [Abstract][Full Text] [Related]
38. Changes by age in breast cancer incidence, mammography screening and hormone therapy use in France from 2000 to 2006.
Séradour B; Allemand H; Weill A; Ricordeau P
Bull Cancer; 2009 Apr; 96(4):E1-6. PubMed ID: 19435691
[TBL] [Abstract][Full Text] [Related]
39. Digital mammography screening in Germany: Impact of age and histological subtype on program sensitivity.
Heidinger O; Heidrich J; Batzler WU; Krieg V; Weigel S; Heindel W; Hense HW
Breast; 2015 Jun; 24(3):191-6. PubMed ID: 25687106
[TBL] [Abstract][Full Text] [Related]
40. Integration of 3D digital mammography with tomosynthesis for population breast-cancer screening (STORM): a prospective comparison study.
Ciatto S; Houssami N; Bernardi D; Caumo F; Pellegrini M; Brunelli S; Tuttobene P; Bricolo P; Fantò C; Valentini M; Montemezzi S; Macaskill P
Lancet Oncol; 2013 Jun; 14(7):583-9. PubMed ID: 23623721
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]